Characterization of ABL1 expression in adult T-cell acute lymphoblastic leukemia by oligonucleotide array analysis

Haematologica

Volumn 92, Issue 5, 2007, Pages 619-626

  Chiaretti, Sabina ^a   Tavolaro, Simona ^a   Ghia, Emanuela Maria ^a   Ariola, Cristina ^a   Matteucci, Caterina ^b   Elia, Loredana ^a   Maggio, Roberta ^a   Messina, Monica ^a   Ricciardi, Maria Rosaria ^a   Vitale, Antonella ^a   Ritz, Jerome ^c   Mecucci, Cristina ^b   Guarini, Anna ^a   Foà, Robin ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

ABL1 expression; Gene expression profile; NUP214 ABL1; T lineage acute lymphoblastic leukemia

Indexed keywords

ABELSON KINASE; ABL 1 PROTEIN; ANTINEOPLASTIC AGENT; BREAKPOINT CLUSTER REGION PROTEIN; UNCLASSIFIED DRUG; BCR ABL PROTEIN; DEK PROTEIN, HUMAN; EML1 ABL1 FUSION PROTEIN, HUMAN; EML1-ABL1 FUSION PROTEIN, HUMAN; HOMEODOMAIN PROTEIN; MESSENGER RNA; NONHISTONE PROTEIN; NUP214 ABL1 FUSION PROTEIN, HUMAN; NUP214-ABL1 FUSION PROTEIN, HUMAN; ONCOPROTEIN; RNA; SIGNAL PEPTIDE; STIL PROTEIN, HUMAN; TLX1 PROTEIN, HUMAN; TLX3 PROTEIN, HUMAN; TUMOR PROTEIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DNA MICROARRAY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE CONTROL; GENE EXPRESSION; GENE OVEREXPRESSION; GENE REARRANGEMENT; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T CELL LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; BIOSYNTHESIS; BLOOD; CLINICAL TRIAL; EVALUATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; MULTICENTER STUDY; NUCLEIC ACID HYBRIDIZATION; ONCOGENE; POLYMERASE CHAIN REACTION; STATISTICS;

ADOLESCENT; ADULT; CHROMOSOMAL PROTEINS, NON-HISTONE; CLINICAL TRIALS; FEMALE; FUSION PROTEINS, BCR-ABL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, LEUKEMIC; GENES, ABL; HOMEODOMAIN PROTEINS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKEMIA, LYMPHOCYTIC, ACUTE, L2; LEUKEMIA, T-CELL, ACUTE; MALE; MULTICENTER STUDIES; NEOPLASM PROTEINS; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENE PROTEINS; ONCOGENE PROTEINS, FUSION; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-ABL; RNA, MESSENGER; RNA, NEOPLASM;

EID: 34447345438     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.10865     Document Type: Article

References (35)

1. Sattler M, Griffin JD. Molecular mechanisms of transformation by the BCR-ABL oncogene. Semin Hematol 2003;40:4-10.
2. De Keersmaecker K, Marynen P, Cools J. Genetic insights in the pathogenesis of T-cell acute lymphoblastic leukemia. Haematologica 2005;90:1116-27.
3. Raanani P, Trakhtenbrot L, Rechavi G, Rosenthal E, Avigdor A, Brok-Simoni F, et al. Philadelphia-chromosome-positive T-lymphoblastic leukemia: acute leukemia or chronic myelogenous leukemia blastic crisis. Acta Haematol 2005;113:181-9.
4. Quentmeier H, Cools J, MacLeod RA, Marynen P, Uphoff CC, Drexler HG. e6-a2 BCR-ABL1 fusion in T-cell acute lymphoblastic leukemia. Leukemia 2005;19:295-6.
5. Graux C, Cools J, Melotte C, Quentmeier A, Ferrando A, Levine R, et al. Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia. Nat Genet 2004;36:1084-9.
6. De Keersmaecker K, Graux C, Odero MD, Mentens N, Somers R, Maertens J, et al. Fusion of EML1 to ABL1 in T-cell acute lymphoblastic leukemia with cryptic t(9;14) (q34;q32). Blood 2005-105: 4849-52.
7. Kim HJ, Woo HY, Koo HH, Tak EY, Kim SH. ABL oncogene amplification with p16(INK4a) gene deletion in precursor T-cell acute lymphoblastic leukemia/lymphoma: report of the first case. Am J Hematol 2004;76:360-3.
8. Barber KE, Martineau M, Harewod L, Stewart M, Cameron E, Strefford JC, et al. Amplification of the ABL gene in T-cell acute lymphoblastic leukemia. Leukemia 2004;18:1153-6.
9. Bernasconi P, Calatroni S, Giardini I, Inzoli A, Castagnola C, Cavigliano PM, et al. ABL1 amplification in T-cell acute lymphoblastic leukemia. Cancer Genet Cytogenet 2005; 162:146-50.
10. Vitale A, Guarini A, Ariola C, Mancini M, Mecucci C, Cuneo A, et al. Adult T-cell acute lymphoblastic leukemia: biologic profile at presentation and correlation with response to induction treatment in patients enrolled in the GIMEMA LAL 0496 protocol. Blood 2006;107:473-9.
11. Mancini M, Scappaticci D, Cimino G, Nanni M, Derme V, Elia L, et al. A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocol. Blood 2005;105:3434-41.
12. Tafuri A, Lemoli RM, Petrucci MT, Ricciardi MR, Fogli M, Bonsi L, et al. Thrombopoietin and interleukin-11 have different modulatory effects on cell cycle and programmed cell death in primary acute myeloid leukemia cells. Exp Hematol 1999;27:1255-63.
13. Chiaretti S, Li X, Gentleman R, Vitale A, Vignetti M, Mandelli F, et al. Gene expression profile of adult T-cell acute lymphocytic leukemia identifies distinct subsets of patients with different response to therapy and survival. Blood 2004;103:2771-8.
14. Chiaretti S, Li X, Gentleman R, Vitale A, Wang KS, Mandelli F, et al. Gene expression profiles of B-line-age adult acute lymphocytic leukemia reveal genetic patterns that identify lineage derivation and distinct mechanisms of transformation. Clin Cancer Res 2005;11:7209-19.
15. Chiaretti S, Guarini A, De Propris MS, Tavolaro S, Intoppa S, Vitale A, et al. ZAP-70 expression in acute lymphoblastic leukemia: association with the E2A/PBX1 rearrangement and the pre-B stage of differentiation and prognostic implications. Blood 2006;107:197-204.
16. Li C, Wong WH. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci USA 2001;98:31-6.
17. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998;95:14863-8.
18. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, et al. Comparative genomic hybridization for molecular cytogenetics analysis of solid tumors. Science 1992;258:818-21.
19. El-Rifai W, Larramendy ML, Bjorkqvist AM, Hemmer S, Knuutila S. Optimization of comparative genomic hybridization using fluorochrome conjugated to dCTP and dUTP nucleotides. Lab Invest 1997;77:699-700.
20. Dierlamm J, Michaux L, La Starza R, Zeller W, Mecucci C, Van den Berghe H. Successful use of the same slide for consecutive fluorescence in situ hybridization experiments. Genes Chromosomes Cancer 1996;16:261-4.
21. Husson H, Carideo EG, Neuberg D, Schultze J, Munoz O, Marks PW, et al. Gene expression profiling of follicular lymphoma and normal germinal center B cells using cDNA arrays. Blood 2002;99:282-9.
22. Bene MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A, et al. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia 1995; 9:1783-6.
23. Carlotti E, Pettenella, Amaru R, Slater S, Lister TA, Barbui T, et al. Molecular characterization of a new recombination of the SIL/TAL-1 locus in a child with T-cell acute lymphoblastic leukaemia. Br J Haematol 2002;118:1011-8.
24. Soekarman D, von Lindern M, van der Plas DC, Selleri L, Bartram CR, Martiat P, et al. Dek-can rearrangement in translocation (6;9)(p23;q34). Leukemia 1992;6:489-94.
25. Soekarman D, von Lindern M, Daenen S, de Jong B, Fonatsch C, Heinze B, et al. The translocation (6;9) (p23;q34) shows consistent rearrangement of two genes and defines a myeloproliferative disorder with specific clinical features. Blood 1992;79:2990-7.
26. Lillington DM, MacCallum PK, Lister TA, Gibbons B. Translocation t(6;9)(p23;q34) in acute myeloid leukemia without myelodysplasia or basophilia: two cases and a review of the literature. Leukemia 1993-7:527-31.
27. Yamane K, Wu X, Chen J. A DNA damage-regulated BRCT-containing protein, TopBP1, is required for cell survival. Mol Cell Biol 2002;22:555-66.
28. Zeng L, Hu Y, Li B. Identification of TopBP1 as a c-Abl-interacting protein and a repressor for c-Abl expression. J Biol Chem 2005;280:29374-80.
29. Cardoso C, Timsit S, Villard L, Khrestchatisky M, Fontes M, Colleaux L. Specific interaction between the XNP/ATR-X gene product and the SET domain of the human EZH2 protein. Hum Mol Genet 1998;7:679-84.
30. Cao R, Wang L, Wang H, Xia L, Erdjument-Bromage H, Tempst P, et al. Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science 2002;298:1039-43.
31. Park J, Wood MA, Cole MD. BAF53 forms distinct nuclear complexes and functions as a critical c-Myc-interacting nuclear cofactor for oncogenic transformation. Mol Cell Biol 2002;22:1307-16.
32. Mancini M, Vegna ML, Castoldi GL, Mecucci C, Spirito F, Elia L, et al. Partial deletions of long arm of chromosome 6: biologic and clinical implications in adult acute lymphoblastic leukemia. Leukemia 2002;16:2055-61.
33. van Vlierberghe P, Meijerink JPP, Lee C, Ferrando AA, Look AT, van Wering ER, et al. A new recurrent 9q34 duplication in pediatric T-cell acute lymphoblastic leukemia. Leukemia 2006;20:1245-53.
34. Ballerini P, Busson M, Fasola S, van den Akker, Lapillonne H, Romana SP, et al. NUP214-ABL1 amplification in t(5;14)/HOX11L2-positive ALL present with several forms and may have prognostic significance. Leukemia 2005;19:468-70.
35. Burmeister T, Gökbuget N, Reinhardt R, Rieder H, Hoelzer D, Schwartz S. NUP214-ABL1 in adult T-ALL. Blood 2006;108:3556-9.